5‐ FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10 ‐Mediated PD ‐ L1 Shedding and Tumour Microenvironment Remodelling
Immunology · 2026-01 · 177 (1) · 170-184
DOI: 10.1111/imm.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 16.09.2025. Verfasst von Bangwu Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases; Clinical Medical Research Institute, First Affi…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Tianshan Talent Cultivation Plan for Young Top Talents Project of Xinjiang Uygur Autonomous Region, Nature Science Foundation of China, Leading Talent Project of Scientific and Technological Innovation in Tianshan Talents Training Plan of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
Chemoresistance remains a major challenge in esophageal squamous cell carcinoma (ESCC) therapy, particularly resistance to 5‐Fluorouracil (5‐FU). This study uncovers how 5‐FU resistance reprograms the tumour microenvironment, primarily through the up‐regulation of ADAM10 and the release of soluble PD‐L1, which collectively facilitate immune evasion. Using a 5‐FU‐resistant AKR mouse ESCC cell line (5‐FU‐AKR) and its parental counterpart, we applied third‐generation DNA sequencing, proteomic analysis, and single‐cell RNA sequencing to unravel the resistance‐associated molecular and cellular shifts. We found that ADAM10 is significantly up‐regulated in 5‐FU‐AKR cells, promoting soluble PD‐L1 release, thereby limiting CD8+ T cell infiltration. Xenograft models further demonstrated enhanced tumourigenicity and immune exclusion in 5‐FU‐resistant tumours. These findings highlight a novel mechanism of immune suppression driven by ADAM10, suggesting that targeting the ADAM10‐PD‐L1 axis may restore anti‐tumour immunity and improve treatment outcomes for 5‐FU‐resistant ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases; Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonom…
- Department of Digestive Internal Medicine, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
- Department of Breast Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
ORCID-Profile: Shutao Zheng
Förderung
- Tianshan Talent Cultivation Plan for Young Top Talents Project of Xinjiang Uygur Autonomous Region
- Nature Science Foundation of China
- Leading Talent Project of Scientific and Technological Innovation in Tianshan Talents Training Plan of Xinjiang Uygur Autonomous Region
- Key Project of Xinjiang Uygur Autonomous Region Natural Science Foundation
- Major Scientific Research Project Cultivation Project of Xinjiang Medical University
- Innovativeteam training project of the First Affiliated Hospital of Xinjiang Medical University(LXM)
- Innovative team training project of the First Affiliated Hospital of Xinjiang Medical University(LXM)
- National Natural Science Foundation of China
Zitieren
APA
Cai, B., Feng, X., Luo, S., Nurbahati, A., Cui, H., Peng, T., Wang, W., Li, H., Liu, Q., Lu, X., & Zheng, S. (2026). 5‐ FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10 ‐Mediated PD ‐ L1 Shedding and Tumour Microenvironment Remodelling. Immunology, 177(1), 170-184. https://doi.org/10.1111/imm.70038
Vancouver
Cai B, Feng X, Luo S, Nurbahati A, Cui H, Peng T, et al. 5‐ FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10 ‐Mediated PD ‐ L1 Shedding and Tumour Microenvironment Remodelling. Immunology. 2026;177(1):170-184. doi:10.1111/imm.70038
BibTeX
@article{Cai2026,
author = {Cai, Bangwu and Feng, Xiaowen and Luo, Shujuan and Nurbahati, Aididar and Cui, Hong and Peng, Tianyuan and Wang, Wei and Li, Huifang and Liu, Qing and Lu, Xiaomei and Zheng, Shutao},
title = {5‐ FU Resistance Facilitates Immune Evasion in Esophageal Squamous Cell Carcinoma Through ADAM10 ‐Mediated PD ‐ L1 Shedding and Tumour Microenvironment Remodelling},
journal = {Immunology},
year = {2026},
volume = {177},
number = {1},
pages = {170--184},
doi = {10.1111/imm.70038}
}
EUVIMED